Correlation of anti-tumour drug resistance with epigenetic regulation.

Autor: Hayashi T; National Hospital Organization, Kyoto Medical Center, Kyoto, Japan. yoyoyo224@hotmail.com.; START-program, Japan Science and Technology Agency (JST), Tokyo, Japan. yoyoyo224@hotmail.com., Konishi I; National Hospital Organization, Kyoto Medical Center, Kyoto, Japan.; Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Jazyk: angličtina
Zdroj: British journal of cancer [Br J Cancer] 2021 Feb; Vol. 124 (4), pp. 681-682. Date of Electronic Publication: 2020 Dec 03.
DOI: 10.1038/s41416-020-01183-y
Abstrakt: During treatment, the development of drug-resistant tumours remains an important challenge in cancer treatment. Epigenetic changes have been reported as one of the mechanisms for anti-tumour drug resistance. In clinical practice, a combination of epigenetic-related drugs can be considered as a future selection of cancer therapeutic drugs.
Databáze: MEDLINE
Externí odkaz: